Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Royal Philips

Founders Frederik Philips Gerard Philips

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 3
Average round size
info
The average size of a deal this fund participated in
$20M
Portfolio companies 3
Rounds per year 0.02
Lead investments 0
Exits 1
Key employees Soon

Areas of investment

  • Biotechnology
  • Product Design
  • Manufacturing
  • Health Diagnostics
  • Medical Device
Summary

The main office of represented Corporate Investor is situated in the Amsterdam. The company was established in Europe in The Netherlands.

The usual things for fund are deals in the range of 5 - 10 millions dollars. The high activity for fund was in 2018. The fund is constantly included in less than 2 deals per year.

The standard case for the fund is to invest in rounds with 6 partakers. The meaningful sponsors for the fund in investment in the same round are Waterline Ventures, Sanofi-Genzyme BioVentures, Qualcomm Ventures.

Among the most popular portfolio startups of the fund, we may highlight Common Sensing. Among the most popular fund investment industries, there are Software, Manufacturing. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund.

Read more

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Arnold Venture Group Seattle, United States, Washington
Autodesk California, San Rafael, United States
CAM Japan, Kanagawa Prefecture, Kawasaki
Central Investments -
China Innovation Venture Partners -
Defenghao Chuangye Touzi Chengguan District, China, Lhasa
DuckDAO -
DV Collective -
Haolu Touzi China, Shanghai
HGTV Knoxville, Tennessee, United States
Indosuez Ventures -
Japan Infrastructure Initiative Company Japan, Tokyo
NetworkAsia Network Services China, Hong Kong, Hong Kong Island
New Vista Capital California, Danville, United States
OCP Angels -
Sanmina Corporation California, San Jose, United States
Sofia Capital Finland, Helsinki, Southern Finland
Triton Alternative Investment Trust -
Venture Gurukool -
Wadi Makkah Makkah, Makkah Region, Saudi Arabia

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Kereos

Biotechnology
Health Care
Life Science
Therapeutics
$19M20 Sep 2005 City of Saint Louis, Missouri, United States
News
BioIntelliSense Raises $45M in Series B Financing

– BioIntelliSense, Inc. from Denver provides continuous health monitoring and clinical intelligence for Remote Patient Monitoring (RPM).
– Series B $45m round was led by Chimera (UAE) and joined by 7wire Technology Partners, Mary Tolan of Chicago Pacific Founders, James Murren formerly of MGM Resorts International, as well as Pendrell Corporation, Royal Philips, and Fresenius Medical Care North America.
– The new investment will be used to accelerate the company’s growth and global expansion.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Royal Philips?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 3
Average round size 20M
Rounds per year 0.02
Peak activity year 2007
Lead investments 0
Exits 1
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Kereos

Biotechnology
Health Care
Life Science
Therapeutics
$19M20 Sep 2005 City of Saint Louis, Missouri, United States
Crunchbase icon

Content report

The following text will be sent to our editors: